Abbott Laboratories ABTT34 Income Statements

Conto economico

Quarter End	Dic 2021	Mar 2022	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	11,47B	11,9B	11,26B	10,41B	10,09B	9,75B	9,98B	10,14B
Reddito operativo	2,38B	2,91B	2,38B	1,77B	1,3B	1,51B	1,54B	1,65B
Reddito ante imposte	2,33B	2,88B	2,35B	1,76B	1,32B	1,56B	1,64B	1,67B
Reddito netto	1,99B	2,45B	2,02B	1,44B	1,03B	1,32B	1,38B	1,44B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	2,44B	2,99B	2,46B	1,86B	1,37B	1,62B	1,72B	1,73B
EBITDA	3,26B	3,74B	3,2B	2,59B	2,22B	2,32B	2,34B	2,47B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	20,85B	27,39B	30,58B	31,9B	34,61B	43,08B	43,65B	40,11B
Reddito operativo	3,19B	1,73B	3,65B	4,53B	5,36B	8,43B	8,36B	6,48B
Reddito ante imposte	1,41B	2,23B	2,87B	4,08B	4,97B	8,21B	8,31B	6,66B
Reddito netto	1,4B	477M	2,37B	3,69B	4,5B	7,07B	6,93B	5,72B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0.951	0.274	1.349	2.092	2.538	4.008	3.99	3.297
UTILE OPERATIVO	2,24B	2,98B	3,62B	4,66B	5,46B	8,7B	8,68B	7B
EBITDA	4,54B	4,75B	6,93B	7,55B	8,68B	11,96B	11,74B	9,82B